Horimoto Y - Search Results

1

ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.

Millour J, de Olano N, Horimoto Y, Monteiro LJ, Langer JK, Aligue R, Hajji N, Lam EW. Millour J, et al. Among authors: horimoto y. Mol Cancer Ther. 2011 Jun;10(6):1046-58. doi: 10.1158/1535-7163.MCT-11-0024. Epub 2011 Apr 25. Mol Cancer Ther. 2011. PMID: 21518729 Free PMC article.

2

ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.

Horimoto Y, Hartman J, Millour J, Pollock S, Olmos Y, Ho KK, Coombes RC, Poutanen M, Mäkelä SI, El-Bahrawy M, Speirs V, Lam EW. Horimoto Y, et al. Am J Pathol. 2011 Sep;179(3):1148-56. doi: 10.1016/j.ajpath.2011.05.052. Epub 2011 Jul 16. Am J Pathol. 2011. PMID: 21763263 Free PMC article.

3

The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma.

Ewington L, Taylor A, Sriraksa R, Horimoto Y, Lam EW, El-Bahrawy MA. Ewington L, et al. Among authors: horimoto y. Cytokine. 2012 Aug;59(2):417-22. doi: 10.1016/j.cyto.2012.04.036. Epub 2012 May 22. Cytokine. 2012. PMID: 22626766

4

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study).

Coombes RC, Tat T, Miller ML, Reise JA, Mansi JL, Hadjiminas DJ, Shousha S, Elsheikh SE, Lam EW, Horimoto Y, El-Bahrawy M, Aboagye EO, Contractor KB, Shaw JA, Walker RA, Marconell MH, Palmieri C, Stebbing J. Coombes RC, et al. Among authors: horimoto y. Ann Oncol. 2013 Apr;24(4):924-30. doi: 10.1093/annonc/mds594. Epub 2012 Dec 11. Ann Oncol. 2013. PMID: 23233650 Free article. Clinical Trial.

5

Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.

Wang J, Taylor A, Showeil R, Trivedi P, Horimoto Y, Bagwan I, Ewington L, Lam EW, El-Bahrawy MA. Wang J, et al. Among authors: horimoto y. Cytokine. 2014 Aug;68(2):94-100. doi: 10.1016/j.cyto.2014.04.005. Epub 2014 May 4. Cytokine. 2014. PMID: 24845798

6

Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.

Horimoto Y, Arakawa A, Harada-Shoji N, Sonoue H, Yoshida Y, Himuro T, Igari F, Tokuda E, Mamat O, Tanabe M, Hino O, Saito M. Horimoto Y, et al. Br J Cancer. 2015 Jan 20;112(2):345-51. doi: 10.1038/bjc.2014.595. Epub 2014 Nov 25. Br J Cancer. 2015. PMID: 25422910 Free PMC article.

7

Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.

Sai S, Vares G, Kim EH, Karasawa K, Wang B, Nenoi M, Horimoto Y, Hayashi M. Sai S, et al. Among authors: horimoto y. Mol Cancer. 2015 Sep 4;14:166. doi: 10.1186/s12943-015-0429-7. Mol Cancer. 2015. PMID: 26338199 Free PMC article.

8

Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex Immunofluorescence.

Badr NM, McMurray JL, Danial I, Hayward S, Asaad NY, Abd El-Wahed MM, Abdou AG, Serag El-Dien MM, Sharma N, Horimoto Y, Sircar T, Vidya R, Hoar F, Rea D, Jones JL, Stevens A, Spooner D, Merard R, Lewis P, Hunter KJ, Berditchevski F, Shaaban AM. Badr NM, et al. Among authors: horimoto y. Pathobiology. 2023;90(1):31-43. doi: 10.1159/000524549. Epub 2022 Jun 15. Pathobiology. 2023. PMID: 35705026 Free article.

9

The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer.

Hayward S, Gachehiladze M, Badr N, Andrijes R, Molostvov G, Paniushkina L, Sopikova B, Slobodová Z, Mgebrishvili G, Sharma N, Horimoto Y, Burg D, Robertson G, Hanby A, Hoar F, Rea D, Eckhardt BL, Ueno NT, Nazarenko I, Long HM, van Laere S, Shaaban AM, Berditchevski F. Hayward S, et al. Among authors: horimoto y. J Pathol. 2020 May;251(1):63-73. doi: 10.1002/path.5415. Epub 2020 Mar 24. J Pathol. 2020. PMID: 32129471

10

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer.

Horimoto Y, Arakawa A, Tanabe M, Sonoue H, Igari F, Senuma K, Tokuda E, Shimizu H, Kosaka T, Saito M. Horimoto Y, et al. BMC Cancer. 2014 Jul 30;14:550. doi: 10.1186/1471-2407-14-550. BMC Cancer. 2014. PMID: 25073969 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page